| Financial Year |
March 31 2023 |
| Monetary Funds |
709,342,408.47 |
| Held-for-trading Financial Assets |
746,451,484.93 |
| Notes Receivable |
8,404,417.45 |
| Accounts Receivable |
315,176,090.10 |
| Advances to Suppliers |
119,855,930.65 |
| Other Receivables |
8,352,927.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
547,349,660.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
290,545,444.77 |
| Total Current Assets |
2,955,497,283.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,413,929,857.75 |
| Under-construction Projects |
1,893,006,622.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
133,086,052.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,243,243.65 |
| Deferred Income Tax Assets |
58,403,452.63 |
| Other Non-Current Assets |
337,588,617.64 |
| Sub-Total of Non-Current Assets |
4,850,832,562.37 |
| Total Assets |
7,806,329,845.41 |
| Short-Term Loans |
315,621,934.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
137,764,963.99 |
| Accounts Payable |
553,079,012.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,435,417.57 |
| Taxes Payable |
16,703,263.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,912,172.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,687,330.32 |
| Other Current Liabilities |
2,323,225.61 |
| Sub-Total of Current Liabilities |
1,144,222,208.58 |
| Long-term Loans |
1,302,548,206.49 |
| Bonds Payable |
972,644,461.46 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
367,112.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,402,206,826.69 |
| Total Liabilities |
3,546,429,035.27 |
| Paid-In Capital(Or Share Stock) |
736,525,851.00 |
| Capital Surplus |
997,699,598.45 |
| Surplus Reserve |
153,846,860.67 |
| LESS:Treasury Stock |
35,161,245.38 |
| Undistributed Profits |
1,454,796,206.66 |
| Minority Stockholder's Interest |
644,793,805.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,615,107,005.09 |
| Owner's Equity（Stockholder's Equity） |
4,259,900,810.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,806,329,845.41 |
